A paper, made visible
Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.
Abstract evidence2 comparisonsAutomated source matching · not expert reviewed
This visual is not yet available
- Available sources do not yet support a numeric visual.
No supported comparison is available to draw
- The paper record remains available. Quantitative pictures appear only when their design, measures and sources are established.